Hepatitis C, Glucagon and Insulin Metabolism in Cirrhotic Patients | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search

Glucagon and Insulin Metabolism in Cirrhotic Patients

Takanori Yoshida, Koichi Ninomiya, Toshifumi Matsumoto, Dolgor Baatar, Toshio Bandoh, Seigo Kitano

First Department of Surgery

Oita Medical University

Oita, Japan



The aim of this study was to investigate glucagon and insulin metabolism in order to clarify the mechanisms that lead to hyperglucagonemia and hyperinsulinemia in cirrhosis.


Splanchnic output and metabolic clearance rates were studied in 16 cirrhotic patients and 5 non-cirrhotic controls. Splanchnic glucagon and insulin output into the portal circulation were calculated by the difference between portal venous and systemic arterial concentration multiplied by portal plasma flow. The metabolic clearance rate was calculated as the ratio of output to systemic arterial concentration. Portal blood flow was measured by continuous local thermodilution.


Arterial glucagon levels were higher in cirrhotics than in controls. Glucagon output was triple of that found in controls (52.4±7.0 vs 17.7±2.9 ng/min, p<0.05). Both groups exhibited similar metabolic clearance rates of glucagon. Systemic arterial insulin values were higher in cirrhotics than in non-cirrhotics. Insulin output was not significantly different between the two groups. However, metabolic clearance of insulin in cirrhotics was reduced to one half of the rate found in controls (237.0±39.8 vs. 450.5±17.5 mL/min, p<0.05).


Hyperglucagonemia in cirrhotic patients results from increased pancreatic output, while hyperinsulinemia results from decreased insulin clearance.